Transcriptional regulation of BK virus by nuclear factor of activated T cells

Journal of Virology

Volumn 84, Issue 4, 2010, Pages 1722-1730

  Jordan, Joslynn A ^a   Manley, Kate ^b   Dugan, Aisling S ^b   O'Hara, Bethany A ^b   Atwood, Walter J ^b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLARGINYLAR GINYLGLYCYLGLYCYLGLYCYLMETHIONYLALANYLGLYCYLPROLYLHISTIDYLPROLYLVALYLISOLEUCYLVA LYLISOLEUCYLTHREONYLGLYCYLPROLYLHISTIDYLGLUTAMYLGLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PEPTIDE; PROTEIN C FOS; PROTEIN C JUN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BK VIRUS; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REACTIVATION; VIRUS STRAIN; VIRUS TRANSCRIPTION;

ANIMALS; BASE SEQUENCE; BINDING SITES; BK VIRUS; CERCOPITHECUS AETHIOPS; DNA PRIMERS; GENES, VIRAL; HUMANS; MUTATION; NFATC TRANSCRIPTION FACTORS; POLYOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS; VERO CELLS;

BK POLYOMAVIRUS; POLYOMAVIRUS;

EID: 75449097853     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01918-09     Document Type: Article

References (54)

1. Abend, J. R., J. A. Low, and M. J. Imperiale. 2007. Inhibitory effect of gamma interferon on BK virus gene expression and replication. J. Virol. 81:272-279.
2. Aramburu, J., M. B. Yaffe, C. Lopez-Rodriguez, L. C. Cantley, P. G. Hogan, and A. Rao. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129-2133.
3. Binet, I., V. Nickeleit, H. H. Hirsch, O. Prince, P. Dalquen, F. Gudat, M. J. Mihatsch, and G. Thiel. 1999. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67:918-922.
4. Chuvpilo, S., C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and E. Serfling. 1993. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21:5694-5704.
5. Crabtree, G. R. 1999. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96:611-614.
6. Di Taranto, C., V. Pietropaolo, G. B. Orsi, L. Jin, L. Sinibaldi, and A. M. Degener. 1997. Detection of BK polyomavirus genotypes in healthy and HIV-positive children. Eur. J. Epidemiol. 13:653-657.
7. Dörries, K., E. Vogel, S. Gunther, and S. Czub. 1994. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59-70.
8. Dugan, A. S., S. Eash, and W. J. Atwood. 2005. An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. J. Virol. 79: 14442-14445.
9. Dugan, A. S., M. L. Gasparovic, N. Tsomaia, D. F. Mierke, B. A. O'Hara, K. Manley, and W. J. Atwood. 2007. Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J. Virol. 81:11798-11808.
10. Eash, S., W. Querbes, and W. J. Atwood. 2004. Infection of Vero cells by BK virus is dependent on caveolae. J. Virol. 78:11583-11590.
11. Faguer, S., H. H. Hirsch, N. Kamar, C. Guilbeau-Frugier, D. Ribes, J. Guitard, L. Esposito, O. Cointault, A. Modesto, M. Lavit, C. Mengelle, and L. Rostaing. 2007. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl. Int. 20:962-969.
12. Gorrill, T. S., and K. Khalili. 2005. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter. Virology 335: 1-9.
13. Halloran, P. F. 2004. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351:2715-2729.
14. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431-3438.
15. Harris, K. F., J. B. Christensen, and M. J. Imperiale. 1996. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J. Virol. 70:2378-2386.
16. Heritage, J., P. M. Chesters, and D. J. McCance. 1981. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J. Med. Virol. 8:143-150.
17. Hirsch, H. H. 2002. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am. J. Transplant. 2:25-30.
18. Hirsch, H. H., D. C. Brennan, C. B. Drachenberg, F. Ginevri, J. Gordon, A. P. Limaye, M. J. Mihatsch, V. Nickeleit, E. Ramos, P. Randhawa, R. Shapiro, J. Steiger, M. Suthanthiran, and J. Trofe. 2005. Polyomavirusassociated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277-1286.
19. Hirsch, H. H., and J. Steiger. 2003. Polyomavirus BK. Lancet Infect. Dis. 3:611-623.
20. Hodur, D. M., and D. Mandelbrot. 2002. Immunosuppression and BKV nephropathy. N. Engl. J. Med. 347:2079-2080.
21. Hoey, T., Y. L. Sun, K. Williamson, and X. Xu. 1995. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2:461-472.
22. Hogan, P. G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232.
23. Howley, P. M. 1980. DNA sequence of human papovavirus BK. Nature 284:124-125.
24. Iwamoto, S., E. Azuma, H. Hori, M. Hirayama, M. Kobayashi, Y. Komada, H. Nishimori, and M. Miyahara. 2002. BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation. Pediatr. Hematol. Oncol. 19:255-261.
25. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:333-342.
26. Josephson, M. A., D. Gillen, B. Javaid, P. Kadambi, S. Meehan, P. Foster, R. Harland, R. J. Thistlethwaite, M. Garfinkel, W. Atwood, J. Jordan, M. Sadhu, M. J. Millis, and J. Williams. 2006. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 81:704-710.
27. Knowles, W. A., P. Pipkin, N. Andrews, A. Vyse, P. Minor, D. W. Brown, and E. Miller. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71:115-123.
28. Latinis, K. M., L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427-31434.
29. Low, J. A., B. Magnuson, B. Tsai, and M. J. Imperiale. 2006. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 80:1361-1366.
30. Luo, C., K. T. Shaw, A. Raghavan, J. Aramburu, F. Garcia-Cozar, B. A. Perrino, P. G. Hogan, and A. Rao. 1996. Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc. Natl. Acad. Sci. USA 93:8907-8912.
31. Macian, F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5:472-484.
32. Macián, F., C. Lopez-Rodriguez, and A. Rao. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20:2476-2489.
33. Manitpisitkul, W., C. Drachenberg, E. Ramos, R. Munivenkatappa, B. Philosophe, D. Klassen, and A. Haririan. 2009. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation 88:83-88.
34. Manley, K., B. A. O'Hara, G. V. Gee, C. P. Simkevich, J. M. Sedivy, and W. J. Atwood. 2006. NFAT4 is required for JC virus infection of glial cells. J. Virol. 80:12079-12085.
35. Manley, K., B. A. O'Hara, and W. J. Atwood. 2008. Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection. Virology 372:48-55.
36. Markowitz, R. B., and W. S. Dynan. 1988. Binding of cellular proteins to the regulatory region of BK virus DNA. J. Virol. 62:3388-3398.
37. Masuda, E. S., Y. Naito, H. Tokumitsu, D. Campbell, F. Saito, C. Hannum, K. Arai, and N. Arai. 1995. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol. Cell. Biol. 15:2697-2706.
38. Moens, U., T. Johansen, J. I. Johnsen, O. M. Seternes, and T. Traavik. 1995. Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis. Virus Genes 10:261-275.
39. Moens, U., and M. Van Ghelue. 2005. Polymorphism in the genome of non-passaged human polyomavirus BK: implications for cell tropism and the pathological role of the virus. Virology 331:209-231.
40. Nickeleit, V., T. Klimkait, I. F. Binet, P. Dalquen, V. Del Zenero, G. Thiel, M. J. Mihatsch, and H. H. Hirsch. 2000. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N. Engl. J. Med. 342:1309-1315.
41. Noguchi, H., M. Matsushita, T. Okitsu, A. Moriwaki, K. Tomizawa, S. Kang, S. T. Li, N. Kobayashi, S. Matsumoto, K. Tanaka, N. Tanaka, and H. Matsui. 2004. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat. Med. 10:305-309.
42. Ramos, E., C. B. Drachenberg, M. Portocarrero, R. Wali, D. K. Klassen, J. C. Fink, A. Farney, H. Hirsch, J. C. Papadimitriou, C. B. Cangro, M. R. Weir, and S. T. Bartlett. 2002. BK virus nephropathy diagnosis and treat-ment: experience at the University of Maryland Renal Transplant Program. Clin. Transpl. 16:143-153.
43. Randak, C., T. Brabletz, M. Hergenrother, I. Sobotta, and E. Serfling. 1990. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J. 9:2529-2536.
44. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
45. Rinaldo, C. H., and H. H. Hirsch. 2007. Antivirals for the treatment of polyomavirus BK replication. Expert Rev. Anti-Infect. Ther. 5:105-115.
46. Rooney, J. W., Y. L. Sun, L. H. Glimcher, and T. Hoey. 1995. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15:6299-6310.
47. Seif, I., G. Khoury, and R. Dhar. 1979. The genome of human papovavirus BKV. Cell 18:963-977.
48. Shah, K. V., R. W. Daniel, and R. M. Warszawski. 1973. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J. Infect. Dis. 128:784-787.
49. Shaw, K. T., A. M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P. G. Hogan. 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA 92:11205-11209.
50. Shinohara, T., M. Matsuda, S. H. Cheng, J. Marshall, M. Fujita, and K. Nagashima. 1993. BK virus infection of the human urinary tract. J. Med. Virol. 41:301-305.
51. Sundsfjord, A., T. Johansen, T. Flaegstad, U. Moens, P. Villand, S. Subramani, and T. Traavik. 1990. At least two types of control regions can be found among naturally occurring BK virus strains. J. Virol. 64:3864-3871.
52. Szabo, S. J., J. S. Gold, T. L. Murphy, and K. M. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13:4793-4805.
53. Trimarchi, J. M., B. Fairchild, R. Verona, K. Moberg, N. Andon, and J. A. Lees. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850-2855.
54. Williams, J. W., B. Javaid, P. V. Kadambi, D. Gillen, R. Harland, J. R. Thistlewaite, M. Garfinkel, P. Foster, W. Atwood, J. M. Millis, S. M. Meehan, and M. A. Josephson. 2005. Leflunomide for polyomavirus type BK nephropathy. N. Engl. J. Med. 352:1157-1158.